Cameron A.Reese

Partner

San Diego + 1.858.314.1192

Connect:

Share

Cameron Reese is an experienced corporate lawyer with a practice focused on mergers and acquisitions and venture capital transactions. Cameron regularly represents private equity funds, emerging companies, venture capital firms, institutional investors, and corporate acquirors in structuring and negotiating a wide range of domestic and cross-border transactions.

Cameron also represents private equity funds in connection with acquisitions and divestitures and provides counsel for many of their portfolio companies. He has experience with leveraged buyout transactions, minority investments and spin-out transactions, and has led transactions on behalf of private equity funds in a number of industry sectors, including health care, life sciences, and technology. The private equity funds with which Cameron has worked include The Riverside Company, Resilience Capital Partners, and Morgenthaler Partners.

Additionally, Cameron has an active emerging companies practice representing both technology and life science companies throughout their entire life cycle, including providing counsel and advise with respect to corporate formation, preferred stock and convertible note financing transactions, corporate governance, strategic relationships, equity incentive arrangements, and mergers and acquisitions. He also advises a number of venture capital and strategic corporate investors in connection with preferred stock financing and joint venture transactions.

Experience

  • Cibus combines with CalyxtJones Day advised Cibus Global, LLC (“Cibus”), a San Diego based leader in precision gene editing in agriculture, in connection with an all-stock merger with Calyxt, Inc. (NASDAQ: CLXT), under which Cibus and Calyxt created an industry-leading company that combines two pioneers in agriculture-based gene editing and establishes one of the world’s most sophisticated facilities for trait development and plant breeding.
  • Organon makes strategic investment in Claria MedicalJones Day advised Organon in the strategic investment in Claria Medical, Inc. a privately-held company developing an investigational medical device being studied for use during minimally invasive laparoscopic hysterectomy.
  • Accelmed Partners makes $35 million investment in SKNV Inc.Jones Day advised Accelmed Partners in its $35 million investment in SKNV Inc., a full continuum-of-care dermatology digital health company for in-practice dispensing and ecommerce of customized prescriptions and skincare.
  • CDPQ leads $125 million Series D financing of Soli OrganicJones Day advised CDPQ as lead investor in the $125 million Series D financing of Soli Organic, the nation's only soil-based, indoor farming company delivering 100% USDA certified organic produce.
  • Riverside portfolio company acquires FoodLogiQ, LLCJones Day advised The Riverside Company in connection with the acquisition by portfolio company ESHA Research of FoodLogiQ, LLC, which provides supply chain management software used by restaurants, food retail and grocery chains, food and beverage product manufacturers, wholesale food suppliers and distributors, and other customers.
  • Baird Capital sells portfolio company Vitalyst to Alithya Group, Inc.Jones Day represented Baird Capital in connection with the sale of its portfolio company Vitalyst, LLC to Alithya Group, Inc.
  • Riverside portfolio company acquires AptoJones Day represented The Riverside Company in connection with the acquisition and financing by portfolio company Buildout, Inc. of Apto, a premier provider of CRM and deal management software for commercial real estate (CRE) brokers.
  • Riverside portfolio company acquires Signal VineJones Day represented The Riverside Company in connection with the acquisition and financing by portfolio company Modern Campus of Signal Vine, the higher education industry’s most impactful two-way text messaging platform.
  • Dorilton Capital sells portfolio company to Specialty Welding and Turnarounds, LLCJones Day represented Dorilton Capital in connection with the sale of portfolio company Midwest Cooling Tower Services, a leading provider of mission-critical cooling tower solutions, including inspection, maintenance and repair, specialty distribution, and rental, to Specialty Welding and Turnarounds, LLC.
  • Qubiqle (d/b/a Plate IQ) raises $160 million from FTV CapitalJones Day advised Qubiqle (d/b/a Plate IQ) in the sale of a majority equity stake to FTV Capital for $160 million.
  • Pattern secures $225 million growth equity investment led by Knox LaneJones Day represented Pattern Inc., a Utah based e-commerce accelerator that helps brands optimize sales on marketplaces like Amazon, Walmart, Target, eBay and Google, in connection with a $225 million Series B Preferred Stock financing transaction, led by Knox Lane.
  • Riverside portfolio companies acquire Intarome Fragrance CorporationJones Day represented The Riverside Company in connection with the acquisition and financing by portfolio companies Premier Specialties, Inc. and Fragrance Solutions Corporation of Intarome Fragrance Corporation, creating a disruptive new fragrance house in the middle-market founded upon decades of experience from three separate well-respected companies.
  • Entravision Communications acquires MediaDonutsJones Day advised Entravision Communications Corporation in its acquisition of MediaDonuts, a digital marketing performance and branding company with operations across seven countries in the Asia-Pacific region.
  • Entravision Communications acquires majority stake in RedmasJones Day represented Entravision Communications Corporation (NYSE: EVC) in the acquisition of a 51% interest in Redmas owned by the Cisneros Interactive Group.
  • GIC participates in $500 million Series G financing round of AffirmJones Day advised GIC, as co-lead investor, in connection with the $500 million Series G round of financing of Affirm.
  • Celularity sold UltraMIST® Ultrasound Therapy wound care assets to SANUWAVE Health, Inc.Jones Day advised Celularity Inc., a New Jersey based venture-backed biotechnology company, in the sale of its UltraMIST® Ultrasound Healing Therapy wound care assets to SANUWAVE Health, Inc. (OTCQB: SNWV).
  • Riverside sells interest in Health and Safety Institute to Waud Capital PartnersJones Day represented The Riverside Company in connection with the sale of its interest in the Health & Safety Institute (“HSI”) to Waud Capital Partners.
  • Stedical Scientific acquires PermeaDerm, Inc.Jones Day advised Stedical Scientific in its acquisition of PermeaDerm, Inc.
  • Health & Safety Institute acquires EMS Safety ServicesJones Day represented The Riverside Company in connection with the add-on acquisition and related financing of EMS Safety Services, Inc., a provider of first aid and CPR training solutions, by portfolio company Health & Safety Institute, a provider of comprehensive health and safety training courses.
  • Riverside invests in Woon-TechJones Day represented The Riverside Company in connection with its investment in and related financing of Woon-Tech, an add-on for its Cardinal platform.
    • View All

    December 2022 Video

    Venture Capital in Crypto Winter

    Before sending, please note:

    Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.